Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc monthly Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-21.63 Insider Own0.10% Shs Outstand327.83M Perf Week11.96%
Market Cap42.48B Forward P/E7.56 EPS next Y17.14 Insider Trans0.54% Shs Float326.90M Perf Month-6.14%
Income-7232.60M PEG- EPS next Q4.31 Inst Own88.50% Short Float1.63% Perf Quarter-11.46%
Sales15.71B P/S2.70 EPS this Y24.90% Inst Trans-1.84% Short Ratio2.06 Perf Half Y-4.47%
Book/sh185.37 P/B0.70 EPS next Y2.91% ROA-7.00% Target Price177.60 Perf Year-24.88%
Cash/sh5.44 P/C23.81 EPS next 5Y3.30% ROE-10.80% 52W Range114.27 - 197.00 Perf YTD-3.06%
Dividend2.96 P/FCF10.19 EPS past 5Y-36.00% ROI-4.80% 52W High-34.23% Beta1.37
Dividend %2.28% Quick Ratio0.60 Sales past 5Y43.40% Gross Margin86.20% 52W Low13.39% ATR4.14
Employees16900 Current Ratio0.70 Sales Q/Q-2.00% Oper. Margin-49.00% RSI (14)51.83 Volatility3.65% 3.37%
OptionableYes Debt/Eq0.38 EPS Q/Q-629.90% Profit Margin-45.90% Rel Volume0.91 Prev Close130.81
ShortableYes LT Debt/Eq0.32 EarningsAug 06 BMO Payout- Avg Volume2.60M Price129.57
Recom2.20 SMA203.57% SMA50-4.04% SMA200-15.07% Volume2,372,796 Change-0.95%
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Jun-24-19 03:17PM  FDA approves Allergan's CoolTone device for toning up abdomen, buttocks and thighs MarketWatch
10:27AM  Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids Zacks
07:30AM  Allergan Receives FDA Clearance For CoolTone Device PR Newswire
Jun-21-19 07:47AM  Allergan's sBLA for Botox for pediatric patients approved by FDA MarketWatch
07:30AM  FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity PR Newswire
Jun-20-19 09:51AM  Allergan (AGN) in Focus: Stock Moves 6.2% Higher Zacks
09:45AM  The Zacks Analyst Blog Highlights: Amgen, Alexion, Regeneron, Allergan and Savara Zacks
09:40AM  Company News For Jun 20, 2019 Zacks
09:23AM  Allergan Up As Analyst Statement Sparks Business Split Rumors Zacks
07:40AM  5 Undervalued Stocks to Buy InvestorPlace
Jun-19-19 05:21PM  Ironwood's Linzess Lowers Abdominal Symptoms in IBS-C Patients Zacks +6.23%
04:20PM  US STOCKS-Stocks approach record as Fed soothes Wall Street's fears Reuters
03:01PM  US STOCKS-Wall Street climbs after Fed signals potential rate cuts Reuters
02:24PM  US STOCKS-Wall Street climbs after Fed signals potential rate cuts Reuters
10:58AM  Allergan Stock Is Moving Up on Expectations of a Breakup Barrons.com
10:29AM  Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data Zacks
10:25AM  US STOCKS-Wall Street pauses with Fed meeting in focus Reuters
10:22AM  Ironwood, Allergan Investors React Positively After Duo's Constipation Drug Found Effective Benzinga
Jun-18-19 04:05PM  Ironwood and Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
01:48PM  Allergan stock jumps 3.8% after Evercore ISI analyst says company is likely heading toward a split MarketWatch
01:05PM  Migraine-Drug Deal Hype Turns Into a Giant Headache Bloomberg
Jun-17-19 08:29AM  3 Big Stock Charts for Monday: Centurylink, Allergan and Charles Schwab InvestorPlace
Jun-15-19 10:07AM  Allergan plc's (NYSE:AGN) Profit Outlook Simply Wall St.
Jun-14-19 08:34AM  Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti Zacks
Jun-13-19 07:13PM  FDA Approves Amgen And Allergan's KANJINTI (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire
04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
Jun-12-19 03:50PM  Pharmaceutical giant Allergan expands in Northwest Austin American City Business Journals
10:23AM  Short Sellers Are Making Bigger Bets Against Teva and Allergan Stock Barrons.com
06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-10-19 04:10PM  Is Allergan plc (AGN) A Good Stock To Buy ? Insider Monkey
09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
Jun-07-19 05:19AM  7 Stocks Ripe for M&A as Trade War Pushes Market Off Record Highs Investopedia
Jun-06-19 09:31AM  Allergan (AGN) Down 9.7% Since Last Earnings Report: Can It Rebound? Zacks
Jun-05-19 09:50AM  Ironwood Initiates Dosing in Mid-Stage Study for MD-7246 Zacks
Jun-03-19 02:00PM  Watch These 9 Companies in a Botox Export Boom Out of South Korea TheStreet.com
May-29-19 04:15PM  Johnson & Johnson Stock Falls as Its Opioid Trial Gets Underway Barrons.com
10:34AM  Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression Zacks
May-28-19 04:58PM  Allergan to recall textured breast implants in Canada Reuters
04:18PM  Allergan to recall textured breast implants in Canada Reuters
12:21PM  Allergan's Vraylar wins U.S. FDA approval for bipolar depression Reuters
11:48AM  Conatus Down More Than 60% in the Past 90 Days: Here's Why Zacks
07:41AM  Allergan's Vraylar wins FDA approval for bipolar depression Reuters
07:30AM  Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression PR Newswire
May-24-19 04:05PM  Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire
May-23-19 10:54AM  David Tepper To Turn Appaloosa Into A Family Office, Focus On Family And Panthers Benzinga
09:15AM  Micron, PG&E, Allergan, Amazon Among Appaloosa's Top Holdings Bloomberg
07:30AM  Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire
May-22-19 02:22PM  He's one of NYC's youngest VCs: Get to know Gen Z investor Patrick Finnegan American City Business Journals
May-20-19 01:18PM  Time to buy ArcelorMittal? Any interest in Alibaba? What about Fitbit? The viewers #AskHalftime CNBC Videos
May-19-19 10:26PM  Edited Transcript of AGN earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-17-19 07:30AM  Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire
May-16-19 09:20AM  Consider This Before Buying Allergan plc (NYSE:AGN) For The 2.2% Dividend Simply Wall St.
07:30AM  Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire
May-15-19 05:08PM  Wallace Weitz Exits Allergan, Trims Liberty Broadband Position GuruFocus.com
07:30AM  Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health PR Newswire
06:00AM  PatientFi® Announces Study Partnership with Allergan Business Wire
May-13-19 03:00PM  Leidos feels effects of a nationally known corporate gadfly American City Business Journals
02:38PM  Drug price fixing allegation may be increasingly problematic for makers: Analyst CNBC Videos
09:27AM  5 Growthy Biotech Stocks to Buy Despite the Scrutiny InvestorPlace
May-10-19 07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
May-09-19 07:30AM  Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire
May-08-19 03:17PM  Botox Competitor Aims to Take Market Share as Allergan Stumbles Bloomberg
May-07-19 04:32PM  Allergan Fended Off Botox Rivalries In The First Quarter But Can It Last? Investor's Business Daily
04:15PM  Allergan stock slips despite revenue beat, a sign of investors worries over companys future MarketWatch
03:21PM  Epipen Parent's Faceplant Is a Cautionary Tale for Botox Maker Bloomberg
03:00PM  What You Need to Know About Allergan's Solid Q1 Performance Motley Fool
01:23PM  Allergan PLC (AGN) Q1 2019 Earnings Call Transcript Motley Fool
01:20PM  Regeneron Stock Could Fall 13% to 52-Week Lows TheStreet.com
12:20PM  Allergan CEO says company is urgently looking at all options to boost share price Reuters
12:06PM  Dow falls 400 points as stocks retreat for second day on U.S.-China tariff worries MarketWatch
09:51AM  Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook TheStreet.com
09:27AM  Allergan (AGN) Beats on Q1 Earnings & Sales, Raises '19 View Zacks
08:59AM  Allergan Stock Slips Despite Beat and Raised Guidance TheStreet.com
08:25AM  Allergan (AGN) Q1 Earnings and Revenues Top Estimates Zacks
07:59AM  Stocks making the biggest moves premarket: Ferrari, Boeing, PepsiCo, Mosaic, Hertz, AIG & more CNBC
07:49AM  Allergan lifts outlook after Botox plumps quarterly earnings Financial Times
07:34AM  Allergan stock down 0.5% despite earnings and revenue beat MarketWatch
07:30AM  Allergan: 1Q Earnings Snapshot Associated Press
07:08AM  Allergan reports bigger first-quarter loss on $2.5 bln charge Reuters
07:00AM  Allergan Reports First Quarter 2019 Financial Results PR Newswire
04:10AM  Stocks - AIG Jumps in Premarket, Anheuser Busch, Boeing Fall, Alphabet Dips Investing.com
02:56AM  Stocks - U.S. Futures Head Lower Again on China Trade Jitters Investing.com
May-06-19 03:35PM  Allergan Expected to Earn $3.55 a Share TheStreet.com
11:11AM  Should You Buy Allergan (AGN) Ahead of Earnings? Zacks
08:50AM  Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the U.S. PR Newswire
May-05-19 07:00AM  Why Are Investors Passing on Teva Pharmaceutical Industries? Motley Fool
May-03-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Allergan (AGN) Zacks
08:36AM  Ironwood (IRWD) Q1 Earnings & Revenues Miss, Shares Fall Zacks
07:45AM  Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire
07:30AM  Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting PR Newswire
06:28AM  Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down Zacks
06:00AM  Stuck Allergan Stock Needs Blowout Q1 News In Next Weeks Earnings Report InvestorPlace
May-02-19 06:46PM  Breast implants tied to rare cancer to remain on US market Associated Press
02:05PM  Allergan Stock Could Break Below Wedge Pattern Investopedia
07:30AM  Allergan Continues to Display Leadership in Neurosciences with 29 Presentations at 2019 American Academy of Neurology Annual Meeting PR Newswire
07:18AM  3M to buy wound-care product maker Acelity in $6.7bn deal Financial Times
May-01-19 12:05PM  Allergan CEO Saunders wins vote to keep chairman role Reuters
11:58AM  Allergan CEO Saunders wins vote to keep chairman role Reuters
09:34AM  Can Allergan (AGN) Beat Earnings Estimates Again in Q1? Zacks
08:49AM  Allergan CEO Saunders wins vote to keep chairman role Reuters
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; and strategic alliance and option agreement with Editas Medicine, Inc. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM